首页> 外国专利> NEW DERIVATIVES OF 9- (3,5-DIMETHOXYPHENYL) -5,8,8A, 9- TETRAHYDROFURO 3 ', 4': 6.7 NAPHTO 2,3-D 1,3 DIOXOL-6 ( 5AH) - ONE, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

NEW DERIVATIVES OF 9- (3,5-DIMETHOXYPHENYL) -5,8,8A, 9- TETRAHYDROFURO 3 ', 4': 6.7 NAPHTO 2,3-D 1,3 DIOXOL-6 ( 5AH) - ONE, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

机译:9-(3,5-二甲氧基苯)-5,8,8A,9-四氢呋喃[3',4':6.7] NAPHTO [2,3-D] [1,3] DIOXOL-6(5AH)的新衍生物-一种,其制备过程和包含它们的药物组合物。

摘要

Compounds of formula (I): (CF DRAWING IN BOPI) in which: R represents: - a group of formula (i): (CF DRAWING IN BOPI) in which X, Y and W are as defined in the description, - or a group of formula (ii): - AG in which: A represents a single bond or an optionally substituted alkylene chain, G represents a group chosen from hydrogen, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, -OR2, -OT 1 -NR3 R4, -OT 1 -NR2 -T1 -NR3 R4, -NR3 R4, -NR2 -T1 -NR3 R4, -NR2 -T1 -OR5, -NR2 -T1 -CO2 R6, -NR2 -T1 -C ( O) R6, -C (O) -NR3 R4, -C (O) -NR2 -T2, -OC (O) -T2, -OC (S) -T2, -NR2 -C (O) -T2, - NR2 -C (S) -T2, -OC (O) -O-T2, -OC (O) -NR2 -T2, -OC (S) -O-T2, -OC (S) -NR2 -T2, - NR2 -C (O) -O-T2, -NR2 -C (O) -NR6 -T2, -NR2 -C (S) -O-T2, -NR2 -C (S} -NR6 -T2, and -NR2 -SO2 -T3, in which R2, R3, R4, R5, R6, T1, T'1, T2 and T3 are as defined in the description tion, R1 represents a group chosen from hydrogen, alkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, alkylcarbonyl, arylcarbonyl, arylalkylcarbonyl, heterocycloalkylcarbonyl, alkylsulfonyl, arylsulfonyl, arylalkylsulfonyl or phosphonic acid, their isomers and their isomers or their isomers a pharmaceutically acceptable base. Medicines.
机译:式(I)的化合物:(CF 3在BOPI中绘制)其中:R代表:-一组式(i):(CF 3在BOPI绘制中)其中X,Y和W如说明书中所定义,-或式(ii)的基团:-AG,其中:A表示单键或任选取代的亚烷基链,G表示选自氢,环烷基,杂环烷基,芳基,杂芳基,-OR 2,-OT 1 -NR 3 R 4的基团,-OT 1 -NR2 -T1 -NR3 R4,-NR3 R4,-NR2 -T1 -NR3 R4,-NR2 -T1 -OR5,-NR2 -T1 -CO2 R6,-NR2 -T1 -C(O)R6, -C(O)-NR3 R4,-C(O)-NR2-T2,-OC(O)-T2,-OC(S)-T2,-NR2-C(O)-T2,-NR2 -C( S)-T2,-OC(O)-O-T2,-OC(O)-NR2 -T2,-OC(S)-O-T2,-OC(S)-NR2-T2,-NR2 -C( O)-O-T2,-NR2-C(O)-NR6-T2,-NR2-C(S)-O-T2,-NR2-C(S} -NR6-T2和-NR2-SO2 -T3 ,其中R 2,R 3,R 4,R 5,R 6,T 1,T'1,T 2和T 3如描述中所定义,R 1代表选自氢,烷基,芳基,芳基烷基,杂芳基,杂芳基烷基,烷基羰基的基团,芳基羰基,芳基烷基羰基杂环烷基羰基,烷基磺酰基,芳基磺酰基,芳基烷基磺酰基或膦酸,它们的异构体和它们的异构体或它们的异构体是药学上可接受的碱。药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号